BACKGROUND: The challenges in gene identification for psychiatric disorders have awakened interest toward quantitative traits and endophenotypes that are potentially more closely related to the underlying biology and provide more power in the linkage and association analyses. Previously, we successfully replicated schizophrenia linkage on chromosome 7q21-32 in Finnish families and demonstrated that an intragenic short tandem repeat (STR) allele of the regional Reelin (RELN) gene is associated with multiple cognitive traits representing central cognitive functions regarded as valid endophenotypes for schizophrenia. METHODS: Here, we used an extended sample of 290 Finnish families with schizophrenia and 375 control subjects in an association analysis between 96 SNPs and three STRs in RELN and diagnostic categories, clinical disorder features, as well as central cognitive functions impaired in schizophrenia. RESULTS: We replicated the original association between RELN intragenic STR allele and working memory in individuals (n = 342) not overlapping with the previous study. This risk allele remained central in the whole study sample by being associated with impaired cognitive functioning and more severe positive and negative symptoms of schizophrenia (p = .0005-.00002). Additionally, multiple SNPs indicated association with the severity of positive symptoms of schizophrenia and together showed potential additive effect on the severity of the symptoms (p = .0000001). However, no significant associations with clinical diagnostic categories emerged. CONCLUSIONS: The strongest effects on cognitive functions were detected among the affected individuals. We thus propose a particular role for RELN as a modifier gene of the pathogenesis of schizophrenia. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
BACKGROUND: The challenges in gene identification for psychiatric disorders have awakened interest toward quantitative traits and endophenotypes that are potentially more closely related to the underlying biology and provide more power in the linkage and association analyses. Previously, we successfully replicated schizophrenia linkage on chromosome 7q21-32 in Finnish families and demonstrated that an intragenic short tandem repeat (STR) allele of the regional Reelin (RELN) gene is associated with multiple cognitive traits representing central cognitive functions regarded as valid endophenotypes for schizophrenia. METHODS: Here, we used an extended sample of 290 Finnish families with schizophrenia and 375 control subjects in an association analysis between 96 SNPs and three STRs in RELN and diagnostic categories, clinical disorder features, as well as central cognitive functions impaired in schizophrenia. RESULTS: We replicated the original association between RELN intragenic STR allele and working memory in individuals (n = 342) not overlapping with the previous study. This risk allele remained central in the whole study sample by being associated with impaired cognitive functioning and more severe positive and negative symptoms of schizophrenia (p = .0005-.00002). Additionally, multiple SNPs indicated association with the severity of positive symptoms of schizophrenia and together showed potential additive effect on the severity of the symptoms (p = .0000001). However, no significant associations with clinical diagnostic categories emerged. CONCLUSIONS: The strongest effects on cognitive functions were detected among the affected individuals. We thus propose a particular role for RELN as a modifier gene of the pathogenesis of schizophrenia. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Authors: Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler Journal: Nat Genet Date: 2005-10-23 Impact factor: 38.330
Authors: Susan Service; Joseph DeYoung; Maria Karayiorgou; J Louw Roos; Herman Pretorious; Gabriel Bedoya; Jorge Ospina; Andres Ruiz-Linares; António Macedo; Joana Almeida Palha; Peter Heutink; Yurii Aulchenko; Ben Oostra; Cornelia van Duijn; Marjo-Riitta Jarvelin; Teppo Varilo; Lynette Peddle; Proton Rahman; Giovanna Piras; Maria Monne; Sarah Murray; Luana Galver; Leena Peltonen; Chiara Sabatti; Andrew Collins; Nelson Freimer Journal: Nat Genet Date: 2006-04-02 Impact factor: 38.330
Authors: Dennis R Grayson; Xiaomei Jia; Ying Chen; Rajiv P Sharma; Colin P Mitchell; Alessandro Guidotti; Erminio Costa Journal: Proc Natl Acad Sci U S A Date: 2005-06-16 Impact factor: 11.205
Authors: Céline Goldberger; David Gourion; Sophie Leroy; Franck Schürhoff; Marie-Chantal Bourdel; Marion Leboyer; Marie-Odile Krebs Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2005-08-05 Impact factor: 3.568
Authors: Lynda El-Hassar; Arthur A Simen; Alvaro Duque; Kiran D Patel; Leonard K Kaczmarek; Amy F T Arnsten; Mark F Yeckel Journal: Biol Psychiatry Date: 2014-01-20 Impact factor: 13.382
Authors: Ming Li; Andrew E Jaffe; Richard E Straub; Ran Tao; Joo Heon Shin; Yanhong Wang; Qiang Chen; Chao Li; Yankai Jia; Kazutaka Ohi; Brady J Maher; Nicholas J Brandon; Alan Cross; Joshua G Chenoweth; Daniel J Hoeppner; Huijun Wei; Thomas M Hyde; Ronald McKay; Joel E Kleinman; Daniel R Weinberger Journal: Nat Med Date: 2016-05-09 Impact factor: 53.440
Authors: Q Xu; X Wu; M Li; H Huang; C Minica; Z Yi; G Wang; L Shen; Q Xing; Y Shi; L He; S Qin Journal: Pharmacogenomics J Date: 2015-08-18 Impact factor: 3.550
Authors: Ming Li; Liang Huang; Maria Grigoroiu-Serbanescu; Sarah E Bergen; Mikael Landén; Christina M Hultman; Andreas J Forstner; Jana Strohmaier; Julian Hecker; Thomas G Schulze; Bertram Müller-Myhsok; Andreas Reif; Philip B Mitchell; Nicholas G Martin; Sven Cichon; Markus M Nöthen; Anna Alkelai; Bernard Lerer; Stéphane Jamain; Marion Leboyer; Frank Bellivier; Bruno Etain; Jean-Pierre Kahn; Chantal Henry; Marcella Rietschel Journal: Mol Neurobiol Date: 2015-12-04 Impact factor: 5.590